ABSTRACT
INTRODUCTION
Tetralogy of Fallot (ToF) is the most common cyanotic heart defect, accounting for approximately 10% of all congenital heart defects (CHD) 1 . After corrective surgery, prognosis is excellent and the majority of cases reach reproductive age 2 . Pregnancy in women with surgically corrected ToF is associated with an increased rate of maternal and neonatal complications 3 -5 . Cardiac complication rates differ largely between studies (ranging from 0 to 17.5%) and obstetric and neonatal complications are described inconsistently.
Impaired uteroplacental circulation plays a central role in the pathogenesis of both obstetric and neonatal complications in the general population 6 . Previous studies on pregnancy in women with CHD showed that maternal cardiac complications and neonatal complications are related and share similar predictors 7, 8 . We therefore hypothesized that maternal cardiac dysfunction may be associated with placental dysfunction and thus with obstetric and neonatal complications in women with CHD. Indeed, in the ZAHARA II (Zwangerschap bij Aangeboren HARtAfwijkingen, pregnancy in congenital heart disease) study, we reported abnormal uteroplacental Doppler flow parameters in women with CHD compared with healthy pregnant women 9, 10 and, in women with CHD, an association was found between prepregnancy right ventricular function and high umbilical artery resistance indices (which are indicative of abnormal placentation), while the abnormal uteroplacental flow was associated with adverse neonatal outcome 10 . In this previous report, we described a mixed population with various types of CHD.
The aim of this prospective study was to investigate the prevalence of cardiac, obstetric and neonatal complications in pregnant women with ToF and in healthy pregnant women. Subsequently, we compared uteroplacental Doppler flow patterns in both groups of women and, in order to explore further the association between uteroplacental circulation and cardiac function, we related cardiac function to uteroplacental Doppler flow patterns in women with ToF.
METHODS
The ZAHARA II study was a prospective multicenter observational cohort study conducted between March 2008 and August 2011. For the current study, we prospectively extended the cohort of pregnant women with ToF included in the ZAHARA II study with consecutive pregnant women with ToF between October 2011 and June 2015 (ZAHARA III). Pregnant women with surgically corrected ToF, aged ≥ 18 years with a gestational age < 20 weeks who presented in one of the participating centers were eligible for enrollment. The healthy controls included in ZAHARA II were recruited from low-risk midwife practices in Groningen and Rotterdam in The Netherlands. The study design and primary results of ZAHARA II have been reported before 9, 10 . Data of 40 women with ToF from ZAHARA II are incorporated in previously published reports 10 -13 . The study protocol was approved by the Research Ethics Committee of the participating centers and all participating women gave written informed consent.
Baseline data and follow-up
Prepregnancy baseline data were collected during the first antenatal visit using medical records. Baseline data that were obtained included maternal age, additional CHDs, prior cardiovascular interventions, previous cardiac events, cardiac medication use, New York Heart Association (NYHA) functional class, modified WHO risk class before pregnancy 14 , 12-lead electrocardiogram, laboratory results, echocardiographic recordings (including parameters concerning ventricular function (left ventricular ejection fraction, tricuspid annular plane systolic excursion (TAPSE), systolic tissue velocities (S ) and valve regurgitation or valve stenosis) smoking prior to pregnancy and obstetric history.
All women visited the cardiac outpatient clinic at 20 and 32 weeks' gestation for clinical evaluation (including NYHA class assessment) and standardized transthoracic echocardiography. Standardized uteroplacental Doppler flow measurements (pulsatility (PI) and resistance (RI) indices of the umbilical and left and right uterine arteries and the presence of early diastolic notching) were performed at the prenatal care outpatient clinic at 20 and 32 weeks' gestation. All transthoracic echocardiographic recordings were evaluated offline by four experienced cardiologists, blinded to the endpoints. Assessment of systolic and diastolic ventricular function, chamber quantification and valvular function were performed according to the current guidelines, as described before 9 .
Cardiac, obstetric and neonatal outcome
Primary maternal cardiovascular events were recorded during pregnancy and up to 6 months postpartum and included any of the following: need for an urgent invasive cardiovascular procedure, heart failure (according to the guidelines of the European Society of Cardiology and documented by the attending physician 15 ), new onset or symptomatic tachy-or bradyarrhythmia requiring new or extended treatment, thromboembolic events, myocardial infarction, cardiac arrest, cardiac death, endocarditis and aortic dissection 9 . Primary obstetric events were defined as instrumental vaginal delivery (vacuum or forceps), Cesarean section (planned or emergency), pregnancy-induced hypertension (systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg, in the absence of proteinuria, measured on two different occasions with a minimal interval of 4 h, occurring ≥ 20 weeks' gestation), pre-eclampsia (pregnancy-induced hypertension with ≥ 0.3 g/24 h proteinuria) 16 , eclampsia (pre-eclampsia with grand mal seizures) 16 , HELLP (hemolysis, elevated liver enzymes, low platelet) syndrome, gestational diabetes mellitus (fasting blood glucose ≥ 6.1 mmol/L and ≥ 7.8 mmol/L after 75-g oral glucose tolerance testing), non-cardiac death, placental abruption, postpartum hemorrhage (>1000 mL blood loss), preterm labor (spontaneous onset of labor < 37 weeks of gestation) and preterm prelabor rupture of membranes (spontaneous rupture of membranes before the onset of uterine contractions and < 37 weeks' gestation) 9 . Neonatal events were fetal death (stillbirth ≥ 20 weeks' gestation), perinatal death (stillbirth ≥ 20 weeks' gestation plus death in the first 28 days following delivery), preterm birth (spontaneous premature birth < 37 weeks' gestation, occurring after preterm labor or preterm prelabor rupture of membranes (PPROM) or indicated preterm birth (induced for fetal or maternal reasons, such as pregnancy-induced hypertension, pre-eclampsia or intrauterine growth restriction)), intraventricular hemorrhage (any grade) 17 , neonatal respiratory distress syndrome (any grade), occurrence of CHD, small-for-gestational age (< 10 th birth-weight percentile, adjusted for gestational age and based on population values in The Netherlands) and low birth weight (< 2500 g) 9 . The PI of the uterine or umbilical artery was considered abnormal if the value exceeded the 95 th percentile reference values according to gestational age in a low-risk patient population 18, 19 . Data from the literature were compared with our current data. A search was performed on PubMed, using the search terms 'congenital heart disease AND pregnancy'. No limits or time restrictions for publication date were used. Relevant reports were selected after reading titles and abstracts. Eligible reports were retrieved and reviewed carefully. Maternal and neonatal outcomes were registered as defined above and tabulated using Microsoft Excel for Windows. Data from the literature were not subjected to statistical testing.
Statistical analysis
For continuous data, depending on their distribution, means and standard deviations (SD) or medians with interquartile range (IQR) were calculated. Absolute numbers and percentages were calculated for categorical data. Student's t-test, the Mann-Whitney U-test, the chi-square test or Fisher's exact test was used for intergroup comparison, as appropriate. Univariate linear regression analysis was used to assess associations between cardiac function and uteroplacental Doppler flow parameters. Multivariate linear regression was omitted since missing data from prepregnancy echocardiograms resulted in a patient cohort that was too small to perform a meaningful analysis.
The following predefined prepregnancy parameters were assessed: maternal age, NYHA functional class, WHO pregnancy risk class, use of cardiac medication, right ventricular diastolic diameter, right ventricular function parameters (TAPSE and right ventricular systolic tissue velocity (S )), left ventricular ejection fraction, mean left ventricular S (septal-lateral), mean left ventricular early diastolic tissue velocity (E ) (septal-lateral) and the presence of valve regurgitation/stenosis. The following variables were assessed at 20 weeks' gestation: high N-terminal pro b-type natriuretic peptide (NT-proBNP; > 128 pg/mL), right ventricular function parameters (TAPSE and right ventricular S ), left ventricular ejection fraction.
Statistical analysis was performed using the STATA software package (version 11, StataCorp LP, College Station, TX, USA). A two-tailed P-value < 0.05 was considered significant.
RESULTS
A total of 62 pregnant women with ToF were eligible for inclusion, of which 64.5% were from the primary ZAHARA II cohort. A total of 71 healthy pregnant women were selected from the participating midwives practices. Two women were excluded (one with a previously undetected atrial septal defect Type II and one who was lost to follow-up), resulting in 69 healthy controls. Table 1 provides the baseline characteristics of women with ToF and healthy pregnant women. The two groups did not differ for mean age and parity, and the majority of women were nulliparous. All women with ToF had undergone complete repair and moderate or severe pulmonary valve regurgitation was present in 60.3%, while 17.9% had moderate or severe pulmonary valve stenosis. Right ventricular dysfunction was present in 21.5% and left ventricular dysfunction in 8.2% of women with ToF.
Baseline and pregnancy outcome
Pregnancy complications in women with ToF and in healthy controls are shown in Table 2 and Figure 1 . No maternal deaths occurred. Cardiac complications were seen in 8.1% of ToF pregnancies, mostly supraventricular arrhythmia. No statistically significant differences in obstetric complications occurred; however, there was a trend towards a higher incidence of pre-eclampsia in women with ToF than in healthy controls (8.1% vs 1.5%, P = 0.071). Gestational age at delivery in women with ToF and in healthy controls was 38.4 ± 2.9 and 39.8 ± 1.5 weeks (P = 0.0012), respectively. Results were comparable after excluding women with a planned Cesarean section. There was no significant trend of higher perinatal mortality rates in neonates of women with ToF. In one case, pregnancy was terminated because of severe CHD in the fetus. One neonate died due to prematurity-related complications 27 weeks after delivery following PPROM at 20 weeks' gestation. A significantly higher proportion of neonates of women with ToF had low birth weight and were more often small for gestational age (Table 2) . This difference persisted after exclusion of women who were treated with beta-blockers.
Uteroplacental Doppler flow measurements
At 32 weeks' gestation, the umbilical artery PI was significantly higher in fetuses of women with ToF than in healthy controls (1.02 ± 0.20 vs 0.94 ± 0.17, P = 0.015; Table 3 ). However, the incidence of abnormal umbilical artery PI at 32 weeks did not significantly differ between the groups (5.6% vs 3.1%, P = 0.50). No differences were found between women with ToF and healthy women for uterine artery PI or RI at 20 or at 32 weeks' gestation (Table 3) . There was no difference in the proportion of women with abnormal uterine artery PI at 20 and 32 weeks' gestation between those with ToF and healthy controls (7.7% vs 3.3%, P = 0.29 and 13.4% vs 6.2%, P = 0.21, respectively). Results were comparable after exclusion of pregnancies with CHD in the fetus. The only difference observed between the two groups was Data are given as mean ± SD or n (%). *Modified World Health Organization class according to ESC guidelines 14 . †Missing data excluded from analysis. ‡Moderate or severe regurgitation. §Peak gradient ≥ 36 mmHg. ¶Ejection fraction < 45%. **Tricuspid annular plane systolic excursion < 16 mm. LV, left ventricular; NYHA, New York Heart Association; RV, right ventricular.
that women with ToF more often had a persisting early diastolic notch (EDN) in the uterine artery at 20 and at 32 weeks than healthy women (9.8% vs 1.5%, P = 0.034 and 7.0% vs 0%, P = 0.025, respectively). In women with ToF, EDN in the uterine artery waveform at 20 weeks was associated with low birth weight (odds ratio (OR), 7.2 (95% CI, 1.2-44.0), P = 0.033). No associations were found between uterine artery PI and RI and neonatal outcome.
Similarly to our previous report on uteroplacental flow and cardiac function, we chose to report on uterine artery RI at 20 weeks' gestation for the regression analysis 10 . Results were comparable for uterine artery RI and PI. For the umbilical artery we used PI, since this was available in 85% of all patients at 32 weeks' gestation. Results of univariable regression are displayed in Table 4 . Right ventricular function parameters prepregnancy and at 20 weeks' gestation showed a correlation with uteroplacental Doppler flow parameters (Figure 2) .
DISCUSSION
This is the first study comparing pregnancy outcome and uteroplacental Doppler flow parameters in women with ToF and in healthy controls. We found that women with ToF experience more cardiovascular complications (in particular arrhythmia) and more neonatal complications, in particular low birth weight and small-for-gestational age. Women with ToF more often had abnormal UDF indices, indicative of defective placentation. Right ventricular function parameters were found to be associated with UDF parameters in these women. UDF parameters were associated with neonatal outcomes.
As can be seen in Figure 1 and Table 2 , the cardiac complication rate in our study was slightly higher (8.1%) than the overall complication rate found in the literature (7.1% cardiac complications during 562 pregnancies in women with ToF) 3 -5,8,20-30 , with more arrhythmia and less heart failure, but rates do differ largely between studies. Differences in study design and patient cohort probably account for these differences.
The obstetric complication rate was not significantly different in women with ToF compared with healthy women, although a trend towards a higher prevalence of hypertensive disorders of pregnancy (pregnancy-induced hypertension, pre-eclampsia, HELLP syndrome) and preterm birth was observed in women with ToF. The obstetric and neonatal complication rates in this study are higher than the incidences found in the literature, but rates differ greatly between studies owing to differences in definitions and, more importantly, underreporting. In this study we found an association between right ventricular parameters (lower prepregnancy TAPSE and lower S , prepregnancy and at 20 and 32 weeks' gestation) and impaired uteroplacental Doppler flow parameters. These findings are in line with our previous study in a larger population with mixed types of CHD, in which lower prepregnancy TAPSE was associated with increased umbilical artery RI 10 . There is increasing evidence of a relationship between cardiac function and poor placentation or placental function, and a role of right ventricular dysfunction in the pathophysiological mechanism has been suggested 31 . A recent systematic review by our group suggested a link between pre-existent subclinical cardiac dysfunction and poor placentation, reflected by high resistance in the uteroplacental circulation 31 . In addition, Wald et al. recently found the decline in cardiac output during pregnancy in women with heart disease to be independently predictive for neonatal complications 32 . There is also evidence that in previously healthy women with high uteroplacental resistance and poor pregnancy outcome there is an increased prevalence of systolic and diastolic left ventricular dysfunction. Additionally, right ventricular systolic and diastolic dysfunction have been described in healthy women with early pre-eclampsia 33 . Melchiorre and colleagues described a higher prevalence of previously unknown functionally significant cardiac defects in women with increased uterine artery Doppler indices 34 . Interestingly, most of these cardiac defects had right-sided sequelae.
The underlying pathophysiological mechanism responsible for these observations might be analogous to what is known in patients with congestive heart failure, in which dysfunction of other organs, including the kidneys and liver, is related to under-perfusion due to left ventricular systolic dysfunction but also to elevated central venous pressure 35, 36 . The placenta may be regarded as a temporary extra organ and may be affected by cardiac dysfunction in a similar way.
The normal placental bed arteries are low-resistance vessels due to remodeling of the spiral artery walls by trophoblast invasion, leaving the autoregulatory capacity of the uteroplacental circulation limited 37, 38 . Therefore, the uteroplacental circulation is dependent directly on maternal cardiac performance. A recent report from Verlohren et al. suggested that placental hypoxia, either as a result of poor trophoblast development or from the inability of the maternal heart to meet the demands of the fetoplacental unit, forms the basis for placenta-related complications 39 reported in the literature ( ), in pregnant women with ToF in current study ( ) and in healthy controls ( ). *P < 0.05 compared with healthy controls. 'Total' represents total percentage of complications mentioned in the figure only. Abruption, placental abruption; CHD, occurrence of congenital heart disease in the fetus; GDM, gestational diabetes mellitus; PB, preterm birth; PE, pre-eclampsia; PIH, pregnancy-induced hypertension; PL, preterm labor; PPH, postpartum hemorrhage; PPROM, preterm prelabor rupture of membranes; SGA, small-forgestational age. with heart disease predictive for neonatal complications 32 . This might suggest that cardiac reserve in women with heart disease is not sufficient to meet the increased demand of the growing fetus and the near-term placenta, leading to adverse neonatal outcome. Right ventricular dysfunction influences left ventricular function through ventriculo-ventricular interdependence, which can lead to decreased cardiac output and therefore insufficient capacity to meet the increased hemodynamic demands of pregnancy. However, right ventricular dysfunction can lead to increased central venous pressure and subsequent venous congestion. Gyselaers et al. postulated that venous hemodynamic dysfunction (i.e. increased venular pressure) may lead to increased pressure in the intervillous space, causing damage to the trophoblast and resulting in defective trophoblastic remodeling of the spiral arteries 40 . Especially the second wave of trophoblastic invasion of the spiral arteries, occurring when intervillous space circulation is established, may be hampered. This may explain the finding of more early diastolic notching at 20 and 32 weeks of gestation and increased resistance in the uterine artery waveforms at 32 weeks in ToF patients. Both hypotheses might be essential parts of the explanation as to why ventricular function parameters are increasingly being found to be associated with altered uteroplacental Doppler flow indices. Further experimental and clinical research with histological examination of the placenta is warranted to explore this association.
Strengths and limitations
This is the first study that investigates uteroplacental circulation during pregnancy in women with ToF and compares pregnancy outcome in these women with that in healthy controls. In addition, the prospective nature of the study makes the results more valuable. Because of the study design, prepregnancy data were collected retrospectively and therefore missing data were inevitable. In addition, the study population was relatively small. As a consequence, multivariate linear regression analysis of the uteroplacental flow indices was not feasible and some of the observed differences in obstetric and neonatal outcomes between women with ToF and controls might not have reached statistical significance. A formal power analysis was not performed since the current study concerns a secondary analysis. Despite a standardized protocol for echocardiograms, availability of cardiac output data was insufficient to incorporate these in the regression analyses. These limitations should be borne in mind and the results interpreted with caution.
Conclusion
Most women with surgically corrected ToF tolerate pregnancy well. However, cardiovascular complications, mainly arrhythmia, are common, and neonatal complications are more frequently observed in women with ToF compared with healthy controls. EDN of the uterine artery waveform occurs more often in women with ToF, which is indicative of disturbed placentation. In addition, umbilical artery PI is higher at 32 weeks' gestation in these women. Right ventricular function parameters, prepregnancy and during pregnancy, are negatively associated with resistance in the uteroplacental circulation. The findings of this study add to the evidence that cardiac dysfunction might play an important role in the placentation process and the occurrence of placenta-related complications in women with CHD. Further fundamental research is required for a better understanding of the underlying pathophysiological mechanism.
